Insulet Corp
NASDAQ:PODD
Insulet Corp
Net Income (Common)
Insulet Corp
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Insulet Corp
NASDAQ:PODD
|
Net Income (Common)
$206.3m
|
CAGR 3-Years
212%
|
CAGR 5-Years
129%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.8B
|
CAGR 3-Years
106%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Insulet Corp's Net Income (Common)?
Net Income (Common)
206.3m
USD
Based on the financial report for Dec 31, 2023, Insulet Corp's Net Income (Common) amounts to 206.3m USD.
What is Insulet Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
129%
Over the last year, the Net Income (Common) growth was 4 385%. The average annual Net Income (Common) growth rates for Insulet Corp have been 212% over the past three years , 129% over the past five years .